Drug Discontinuation, Effectiveness, and Safety in Clinical Trial Eligible vs Ineligible Patients

This observational study examines whether drug discontinuation, effectiveness, and rates of serious adverse events differ in patients with psoriasis being treated with biologics who have been categorized as eligible or ineligible for clinical trials.

https://ift.tt/2pM8peg